Myriad myPlan Lung Cancer Test Launched to Leading Oncologists

Myriad Genetics has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan Lung Cancer is an RNA expression panel to determine a patient's risk of dying from lung cancer within five years.
FirstWord MedTech